2020
DOI: 10.1016/j.jinf.2020.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study

Abstract: SARS-CoV-2 Anosmia Dysguageusia Loss of smell Positive predictive value Viral load s u m m a r y Objectives: To determine the frequency of SARS-CoV-2 positive samples in a subset of patients consulting for primarily isolated acute (< 7 days) loss of smell and to assess the diagnostic accuracy of olfactory/gustatory dysfunction for COVID-19 diagnosis in the overall population tested for COVID-19 in the same period. Methods: Prospective multicentric cohort study in four olfactory ENT units and a screening center… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

11
49
0
4

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(65 citation statements)
references
References 22 publications
(26 reference statements)
11
49
0
4
Order By: Relevance
“…The most prevalent symptoms were: asthenia, headache and cough (63.36%, 60.22% and 60. 08% respectively), similar to those reported in other series (16,19,20) . The symptomatology that was signi cantly associated to the SARS-CoV-2 infection was the presence of anosmia, with an OR of 3.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…The most prevalent symptoms were: asthenia, headache and cough (63.36%, 60.22% and 60. 08% respectively), similar to those reported in other series (16,19,20) . The symptomatology that was signi cantly associated to the SARS-CoV-2 infection was the presence of anosmia, with an OR of 3.…”
Section: Discussionsupporting
confidence: 91%
“…The second analytical model that included symptoms signi cantly associated with the SARS-CoV-2 infection (3 or more symptoms) such as anosmia, myalgia, asthenia, headache, eye pain, and malaise, yielded a sensitivity of 91.2% and speci city of 55.6% for SARS-CoV-2 positivity. Salmon et al, (19) performed a prospective, multicenter observational study at 5 hospitals in Paris to determine the frequency of SARS-CoV-2 positive patients with a loss of sense of smell; and to analyze the diagnostic accuracy of olfactory and gustatory dysfunction for the diagnosis of COVID-19. A total of 1,824 patients were included in the second phase of the study, out of whom 849 (46.5%) tested positive for SARS-CoV-2.…”
Section: Discussionmentioning
confidence: 99%
“…The change in smell ability is not related to nasal obstruction, as nose blockage was low, in accord with previous studies [7,23]. Taste and chemesthesis changes strongly correlate with smell change (also shown and discussed by Parma [7]).…”
Section: Discussionsupporting
confidence: 90%
“…The multicenter CORANOSMIA cohort study. 1 ” Loss of smell without nasal obstruction was commonly found in the coronavirus disease 2019 (COVID-19), accounting for more than 50% of Western patients. 2 The main suspected etiological mechanism consists of the virus spread through the neuroepithelium of the olfactory cleft and a related neuronal cell destruction.…”
mentioning
confidence: 99%